Aprea Therapeutics, Inc. (APRE) Balance Sheet
APRE balance sheet, 2025
December 31, 2025 · U.S. dollars$15.9M assets = $3.5M liabilities + $12.4M equity
Both columns are drawn to the same scale: what APRE owns equals what it owes plus shareholders’ equity. Hover a block for its value.
APRE financial health
Descriptive bands, not a rating. Fiscal 2025.
APRE balance sheet trends, 2017–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $24.8M2017 | $15.9M2025 | −5.4%/yr | |
| Total liabilities | $60.5M2017 | $3.5M2025 | −30.0%/yr | |
| Shareholders’ equity | −$35.8M2017 | $12.4M2025 | — | |
| Cash & short-term investments | $24.4M2017 | $14.6M2025 | −6.2%/yr | |
| Total debt | $02017 | $190,4712021 | — | |
| Net cash (debt) | $24.4M2017 | $52.9M2021 | +$28.5M | |
| Working capital | $20.4M2017 | $12.8M2025 | −$7.6M | |
| Book value per share | $5.052023 | $1.902025 | −38.6%/yr | |
| Current ratio | 5.752017 | 5.632025 | −0.12 | |
| Debt / equity | 0.002019 | 0.002021 | 0.00 | |
| Shares outstanding | 3.6M2023 | 6.5M2025 | +34.4%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
APRE assets
APRE liabilities and equity
APRE debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
APRE balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & short-term investments | $14.6M | $22.8M | $21.6M | $28.8M | $53.1M | $89.0M | $130.1M | $65.7M | $24.4M |
| Cash & equivalents | $14.6M | $22.8M | $21.6M | $28.8M | $53.1M | $89.0M | $130.1M | $65.7M | $24.4M |
| Short-term investments | — | — | — | — | — | — | — | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $961,899 | $726,254 | $914,275 | $1.4M | $3.5M | $3.4M | $3.0M | $322,146 | $329,859 |
| Total current assets | $15.6M | $23.6M | $22.5M | $30.2M | $56.6M | $92.4M | $133.0M | $66.0M | $24.7M |
| Property, plant & equipment (net) | $59,807 | $81,522 | $88,362 | $2,321 | $209,681 | $359,131 | $563,031 | $24,450 | $30,336 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $312,348 | $321,832 | $40,717 | $0 | $29,372 | $29,383 | $107 | $111 | $121 |
| Total assets | $15.9M | $24.0M | $22.7M | $30.2M | $56.8M | $92.8M | $133.6M | $66.0M | $24.8M |
| Liabilities | |||||||||
| Accounts payable | $713,668 | $1.4M | $1.7M | $842,754 | $1.8M | $4.5M | $2.2M | $1.7M | $1.7M |
| Short-term debt | — | — | — | — | $190,471 | $256,309 | $242,329 | $0 | $0 |
| Deferred revenue | — | — | $528,974 | — | — | — | — | — | — |
| Total current liabilities | $2.8M | $3.4M | $4.4M | $3.2M | $7.3M | $15.3M | $9.1M | $4.9M | $4.3M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | — | — | — | $0 | $190,471 | $335,156 | $544,950 | $0 | $0 |
| Other long-term liabilities | $727,361 | $1.3M | $1.3M | $1.3M | $2.0M | $78,847 | $302,621 | $112.6M | $56.2M |
| Total liabilities | $3.5M | $4.7M | $4.4M | $4.5M | $7.3M | $15.4M | $9.4M | $117.5M | $60.5M |
| Shareholders' equity | |||||||||
| Common stock & paid-in capital | $8,192 | $5,481 | $3,736 | $2,655 | $1,092 | $21,187 | $21,023 | $127,091 | $126,838 |
| Retained earnings (deficit) | −$333.6M | −$321.0M | −$308.1M | −$293.8M | −$181.1M | −$144.0M | −$90.5M | −$62.5M | −$46.9M |
| Treasury stock | — | — | — | — | — | — | — | $0 | $0 |
| Accumulated other comprehensive income | −$10.6M | −$10.6M | −$10.6M | −$10.6M | −$10.4M | −$10.0M | −$11.5M | −$8.8M | −$8.3M |
| Minority interest | — | — | — | — | — | — | — | $0 | $0 |
| Total shareholders' equity | $12.4M | $19.3M | $18.3M | $25.6M | $49.5M | $77.4M | $124.2M | −$51.4M | −$35.8M |
| Key figures | |||||||||
| Total debt | — | — | — | — | $190,471 | $335,156 | $544,950 | $0 | $0 |
| Net cash (debt) | — | — | — | — | $52.9M | $88.7M | $129.5M | $65.7M | $24.4M |
| Working capital | $12.8M | $20.2M | $18.1M | $27.0M | $49.3M | $77.1M | $124.0M | $61.1M | $20.4M |
| Tangible book value | $12.4M | $19.3M | $18.3M | $25.6M | $49.5M | $77.4M | $124.2M | −$51.4M | −$35.8M |
| Book value per share | $1.90 | $3.50 | $5.05 | — | — | — | — | — | — |
| Shares outstanding | 6.5M | 5.5M | 3.6M | — | — | — | — | — | — |
| Current ratio | 5.63 | 7.01 | 5.14 | 9.42 | 7.73 | 6.03 | 14.68 | 13.56 | 5.75 |
| Quick ratio | 5.28 | 6.80 | 4.93 | 8.99 | 7.25 | 5.81 | 14.36 | 13.49 | 5.67 |
| Debt / equity | — | — | — | — | 0.00 | 0.00 | 0.00 | — | — |
| Equity / assets | 78.1% | 80.5% | 80.6% | 85.0% | 87.1% | 83.4% | 93.0% | −77.9% | −144.4% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $41.2M | $46.5M | $14.6M | $13.7M | $16.5M | $19.3M | $22.8M | $26.2M | $28.7M | $32.4M | $21.6M | $25.4M |
| Cash & equivalents | $41.2M | $46.5M | $14.6M | $13.7M | $16.5M | $19.3M | $22.8M | $26.2M | $28.7M | $32.4M | $21.6M | $25.4M |
| Receivables | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $679,686 | $779,238 | $961,899 | $225,936 | $395,011 | $558,689 | $726,254 | $234,195 | $865,092 | $698,864 | $914,275 | $286,263 |
| Total current assets | $41.9M | $47.2M | $15.6M | $13.9M | $16.9M | $19.8M | $23.6M | $26.5M | $29.6M | $33.1M | $22.5M | $25.6M |
| Property, plant & equipment (net) | $64,033 | $54,379 | $59,807 | $65,236 | $70,665 | $76,093 | $81,522 | $86,950 | $92,379 | $90,183 | $88,362 | $86,198 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $312,777 | $812,567 | $312,348 | $312,092 | $311,835 | $311,580 | $321,832 | $323,199 | $312,422 | $40,986 | $40,717 | $40,449 |
| Total assets | $42.3M | $48.1M | $15.9M | $14.3M | $17.3M | $20.2M | $24.0M | $26.9M | $30.0M | $33.2M | $22.7M | $25.8M |
| Liabilities | ||||||||||||
| Accounts payable | $935,139 | $2.9M | $713,668 | $641,322 | $1.2M | $1.3M | $1.4M | $1.2M | $964,327 | $1.3M | $1.7M | $862,552 |
| Deferred revenue | — | — | — | — | — | — | — | — | $50,739 | $148,405 | $528,974 | — |
| Total current liabilities | $3.1M | $5.3M | $2.8M | $2.7M | $3.2M | $3.4M | $3.4M | $3.6M | $3.1M | $3.0M | $4.4M | $4.2M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $727,361 | $727,361 | $727,361 | $727,361 | $727,361 | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M |
| Total liabilities | $3.8M | $5.3M | $3.5M | $2.7M | $3.9M | $4.7M | $4.7M | $4.9M | $3.1M | $4.3M | $4.4M | $5.5M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $12,391 | $11,983 | $8,192 | $5,979 | $5,752 | $5,513 | $5,481 | $5,435 | $5,430 | $5,430 | $3,736 | $3,736 |
| Retained earnings (deficit) | −$340.5M | −$336.9M | −$333.6M | −$331.2M | −$328.2M | −$325.0M | −$321.0M | −$318.1M | −$314.4M | −$310.9M | −$308.1M | −$304.6M |
| Accumulated other comprehensive income | −$10.6M | −$10.6M | −$10.6M | −$10.6M | −$10.6M | −$10.6M | −$10.6M | −$10.6M | −$10.6M | −$10.6M | −$10.6M | −$10.6M |
| Total shareholders' equity | $38.5M | $42.8M | $12.4M | $11.6M | $13.4M | $15.5M | $19.3M | $21.9M | $26.9M | $28.9M | $18.3M | $20.3M |
| Key figures | ||||||||||||
| Working capital | $38.8M | $41.9M | $12.8M | $11.3M | $13.8M | $16.5M | $20.2M | $22.8M | $26.5M | $30.1M | $18.1M | $21.5M |
| Tangible book value | $38.5M | $42.8M | $12.4M | $11.6M | $13.4M | $15.5M | $19.3M | $21.9M | $26.9M | $28.9M | $18.3M | $20.3M |
| Book value per share | $0.72 | $2.92 | $1.62 | $1.83 | $2.21 | $2.59 | $3.24 | $3.69 | $4.53 | $6.89 | $4.89 | $5.43 |
| Shares outstanding | 53.5M | 14.7M | 7.7M | 6.4M | 6.1M | 6.0M | 6.0M | 5.9M | 5.9M | 4.2M | 3.7M | 3.7M |
| Current ratio | 13.55 | 8.92 | 5.63 | 5.20 | 5.34 | 5.90 | 7.01 | 7.28 | 9.55 | 11.15 | 5.14 | 6.15 |
| Quick ratio | 13.33 | 8.77 | 5.28 | 5.12 | 5.22 | 5.73 | 6.80 | 7.22 | 9.27 | 10.92 | 4.93 | 6.09 |
| Equity / assets | 91.0% | 89.0% | 78.1% | 81.3% | 77.5% | 76.9% | 80.5% | 81.6% | 89.7% | 87.1% | 80.6% | 78.7% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 16, 2026); data from EODHD.
APRE financial position
At the end of fiscal 2025 (December 31, 2025), Aprea Therapeutics had total assets of $15.9 million (down 33.6% from a year earlier), total liabilities of $3.5 million and shareholders' equity of $12.4 million. Its current ratio was 5.63. In the latest quarter (ended June 30, 2026) total assets were $42.3 million and equity $38.5 million.
Related: APRE income statement, APRE cash flow statement, APRE key metrics. See the APRE stock overview for the latest quote and news.
APRE balance sheet FAQ
What are Aprea Therapeutics's total assets?
Aprea Therapeutics reported total assets of $15.9 million at the end of fiscal 2025 (December 31, 2025), compared with $24.0 million a year earlier.
How much cash does Aprea Therapeutics have?
Aprea Therapeutics held $14.6 million in cash and short-term investments at the end of fiscal 2025.
What is Aprea Therapeutics's book value?
Aprea Therapeutics's shareholders' equity (book value) was $12.4 million at the end of fiscal 2025, or $1.90 per share.
What is Aprea Therapeutics's current ratio?
Aprea Therapeutics had current assets of $15.6 million and current liabilities of $2.8 million, a current ratio of 5.63 (it can cover its short-term obligations).